Estrella Immunopharma (ESLAW) SEC Filings & 10K Form

$0.10

0.00 (0.00%)

(As of 09/6/2024 ET)

Compare

Stock Analysis Chart Competitors Financials SEC Filings Trends

Recent Estrella Immunopharma SEC Filings

Filing Types

Ownership Filings

Time Frame

Start Date

End Date

Export to Excel

Date	Filer	Form Type
08/23/2024 2:11 PM	Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma (Issuer) Zhang Hong (Reporting)	Form 3 Initial statement of beneficial ownership of securities
08/21/2024 3:55 PM	Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma (Filer)	Form 424B3
08/20/2024 4:00 PM	Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
08/06/2024 9:22 AM	Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma (Filer)	Form 424B3
07/02/2024 2:34 PM	Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma (Filer)	Form 424B3
05/15/2024 3:21 PM	Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma (Filer)	Form 424B3
05/14/2024 8:49 PM	Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma (Filer)	Form 10-Q General form for quarterly reports under Section 13 or 15(d)
Get the Latest News and Ratings for ESLAW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Estrella Immunopharma and its competitors with MarketBeat's FREE daily newsletter.
05/13/2024 4:28 PM	Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
04/10/2024 5:14 AM	Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
03/08/2024 8:25 PM	Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
03/08/2024 8:28 PM	Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma (Filer)	Form 424B3
03/06/2024 8:49 PM	Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
02/14/2024 4:28 PM	Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma (Filer)	Form 10-Q General form for quarterly reports under Section 13 or 15(d)
02/02/2024 7:30 AM	Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
01/30/2024 10:29 AM	Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
12/28/2023 11:15 PM	Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma (Filer)	Form EFFECT
12/28/2023 3:56 PM	Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma (Filer)	Form 424B3
12/15/2023 8:58 PM	Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma (Filer)	Form S-1/A
11/20/2023 4:12 PM	Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma (Filer)	Form 10-Q General form for quarterly reports under Section 13 or 15(d)
11/14/2023 8:31 PM	Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma (Filer)	Form NT 10-Q
11/13/2023 4:21 PM	Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma (Filer)	Form S-1/A
10/27/2023 6:27 PM	Estrella Immunopharma, Inc. (Subject) Estrella Immunopharma, Inc. (Subject) Estrella Immunopharma, Inc. (Subject) Estrella Immunopharma, Inc. (Subject) Estrella Immunopharma (Subject) Eureka Therapeutics, Inc. (Filed by)	Form SC 13D
10/10/2023 6:50 PM	Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma (Filer)	Form S-1 Registration statement under Securities Act of 1933
10/10/2023 3:15 PM	Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma (Issuer) Wu Fan (Reporting)	Form 3 Initial statement of beneficial ownership of securities
10/10/2023 3:16 PM	Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma (Issuer) Wu Xuejun Janelle (Reporting)	Form 3 Initial statement of beneficial ownership of securities
10/10/2023 3:16 PM	Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma (Issuer) Liu Cheng (Reporting)	Form 3 Initial statement of beneficial ownership of securities
10/10/2023 3:17 PM	Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma (Issuer) Xu Pei (Reporting)	Form 3 Initial statement of beneficial ownership of securities
10/10/2023 3:17 PM	Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma (Issuer) Roberts Marsha (Reporting)	Form 3 Initial statement of beneficial ownership of securities
10/10/2023 3:18 PM	Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma (Issuer) Xu Jiandong (Reporting)	Form 3 Initial statement of beneficial ownership of securities
10/05/2023 3:56 PM	Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma, Inc. (Filer) Estrella Immunopharma (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
10/05/2023 3:15 PM	ALTMAN JEFFREY A (Reporting) ALTMAN JEFFREY A (Reporting) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma (Issuer) Owl Creek Asset Management, L.P. (Reporting) Owl Creek Asset Management, L.P. (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
10/05/2023 12:14 PM	Estrella Immunopharma, Inc. (Subject) Estrella Immunopharma, Inc. (Subject) Estrella Immunopharma, Inc. (Subject) Estrella Immunopharma, Inc. (Subject) Estrella Immunopharma (Subject) Nasdaq Stock Market LLC (Filed by)	Form 25-NSE
10/02/2023 3:00 PM	Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma (Issuer) Wen Luqi (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
10/02/2023 3:00 PM	Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma (Issuer) Long James (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
10/02/2023 3:00 PM	Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma (Issuer) TradeUP Acquisition Sponsor LLC (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
10/02/2023 3:00 PM	Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma (Issuer) Yang Weiguang (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
10/02/2023 3:00 PM	Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma (Issuer) Twigg Weston (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
10/02/2023 3:00 PM	Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma (Issuer) Li Jianwei (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
10/02/2023 3:00 PM	Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma, Inc. (Issuer) Estrella Immunopharma (Issuer) Jiang Tao (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
09/20/2023 2:46 PM	TradeUP Acquisition Corp. (Filer) TradeUP Acquisition Corp. (Filer) TradeUP Acquisition Corp. (Filer) TradeUP Acquisition Corp. (Filer) Estrella Immunopharma (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
09/20/2023 2:47 PM	TradeUP Acquisition Corp. (Subject) TradeUP Acquisition Corp. (Subject) TradeUP Acquisition Corp. (Subject) TradeUP Acquisition Corp. (Subject) Estrella Immunopharma (Subject)	Form 425
Biden’s Capital Gains Tax to Devastate Savings! (Ad) Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security. >> Get Your FREE Wealth Protection Guide <<
09/18/2023 4:27 PM	TradeUP Acquisition Corp. (Filer) TradeUP Acquisition Corp. (Filer) TradeUP Acquisition Corp. (Filer) TradeUP Acquisition Corp. (Filer) Estrella Immunopharma (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
09/18/2023 4:29 PM	TradeUP Acquisition Corp. (Subject) TradeUP Acquisition Corp. (Subject) TradeUP Acquisition Corp. (Subject) TradeUP Acquisition Corp. (Subject) Estrella Immunopharma (Subject)	Form 425